# Effect of Cenicriviroc on HIV Neurocognitive Impairment

> **NCT02128828** · PHASE2 · COMPLETED · sponsor: **University of Hawaii** · enrollment: 20 (actual)

## Conditions studied

- AIDS Dementia Complex
- HIV-1-Associated Cognitive Motor Complex
- Human Immunodeficiency Virus

## Interventions

- **DRUG:** cenicriviroc

## Key facts

- **NCT ID:** NCT02128828
- **Lead sponsor:** University of Hawaii
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02128828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02128828, "Effect of Cenicriviroc on HIV Neurocognitive Impairment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02128828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*